These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4868796)

  • 1. Long-acting phenothiazine (fluphenazine decanoate) treatment of psychosis.
    Keskiner A; Simeon J; Fink M; Itil TM
    Arch Gen Psychiatry; 1968 Apr; 18(4):477-81. PubMed ID: 4868796
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects.
    van Praag HM; Dols LC
    Am J Psychiatry; 1973 Jul; 130(7):801-4. PubMed ID: 4576449
    [No Abstract]   [Full Text] [Related]  

  • 3. Depot phenothiazine treatment in acute psychosis: a sequential comparative clinical study.
    Chien CP; Cole JO
    Am J Psychiatry; 1973 Jan; 130(1):13-8. PubMed ID: 4566388
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and biological effects of fluphénazine décanoate. 35 cases].
    Borenstein P; Dumaine A; Cujo P
    Ann Med Psychol (Paris); 1970 Jul; 2(2):267-73. PubMed ID: 5475413
    [No Abstract]   [Full Text] [Related]  

  • 5. A trial of fluphenazine enanthate in chronic schizophrenia.
    Millar J; Daniel GR
    Br J Psychiatry; 1967 Dec; 113(505):1431-2. PubMed ID: 4865296
    [No Abstract]   [Full Text] [Related]  

  • 6. Outpatient treatment of psychotic patients with a long-acting phenothiazine: fluphenazine decanoate.
    Kinzie JD; Simons RC
    Med J Malaya; 1971 Dec; 26(2):129-32. PubMed ID: 4260859
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluphenazine enanthate for the difficult psychotic patient.
    Stewart AR; Lavallee B
    Dis Nerv Syst; 1969 Feb; 30(2):98-102. PubMed ID: 5774574
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical effectiveness of oral and parenteral rapid neuroleptization.
    Coffman JA; Nasrallah HA; Lyskowski J; McCalley-Whitters M; Dunner FJ
    J Clin Psychiatry; 1987 Jan; 48(1):20-4. PubMed ID: 3542982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the problem of the therapeutical axis symptom of neuroleptic medicaments].
    Glatzel J
    Psychiatr Neurol Med Psychol (Leipz); 1968 Aug; 20(8):286-95. PubMed ID: 5731884
    [No Abstract]   [Full Text] [Related]  

  • 10. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled trials of an amitriptyline-fluphenazine combination in depressive neuroses and psychoses: a collaborative study.
    Baldini JT; Neary ER
    Curr Ther Res Clin Exp; 1970 Feb; 12(2):84-93. PubMed ID: 4984324
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study of two long acting phenothiazine preparations, fluphenazine-enanthate and fluphenazine-decanoate.
    Kurland AA; Richardson JH
    Psychopharmacologia; 1966; 9(4):320-7. PubMed ID: 4871473
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of psychoses with a long-acting neuroleptic agent (fluphenazine decanoate). Clinico-psychopathological study of 53 patients].
    La Mura G; Specchio LM; Corfiati L; Porro V; Bertolino A
    Acta Neurol (Napoli); 1974; 29(4):446-59. PubMed ID: 4615572
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluphenazine in the long term treatment of psychoses. A preliminary communication.
    Gunby B; Brun H; Hartviksen I
    Acta Psychiatr Scand Suppl; 1968; 203():225-30. PubMed ID: 4881876
    [No Abstract]   [Full Text] [Related]  

  • 15. A controlled comparative study of fluphenazine and fluphenazine enanthate in acute and chronic psychotic patients.
    van Praag HM; Breetveld J; van Mesdag-Etty H; Westerhuis R; Pen A; Schut T
    Psychiatr Neurol Neurochir; 1970; 73(3):165-75. PubMed ID: 4912332
    [No Abstract]   [Full Text] [Related]  

  • 16. Depot fluphenazine: risk/benefit ratio.
    Glazer WM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Direct treatment of psychotic symptoms with an incisive neuroleptic (Dapotum Acutum)].
    Bermejo E
    Rev Med Suisse Romande; 1976 Dec; 96(12):951-3. PubMed ID: 1006000
    [No Abstract]   [Full Text] [Related]  

  • 18. High doses of fluphenazine enanthate in schizophrenia. A controlled study.
    Dencker SJ; Johansson R; Lundin L; Malm U
    Acta Psychiatr Scand; 1978 May; 57(5):405-14. PubMed ID: 354329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluphenazine decanoate: fifty cases over seven years--a report.
    Yesavage JA; Masson JA; Bretonneau CH
    Psychopharmacol Bull; 1978 Jul; 14(3):8-9. PubMed ID: 353874
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia.
    Johnson DA; Malik NA
    Acta Psychiatr Scand; 1975 May; 51(4):257-67. PubMed ID: 1096536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.